T1	PROC 123 131	tratados
#1	AnnotatorNotes T1	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T2	DISO 83 106	enfermedad de Alzheimer
#2	AnnotatorNotes T2	C0002395; Alzheimer's Disease; Disease or Syndrome
T3	CHEM 55 65	Lu AE58054
#3	AnnotatorNotes T3	C3253508; Lu AE58054; Organic Chemical · Pharmacologic Substance
T4	CHEM 139 174	inhibidor de la acetilcolinesterasa
T5	PROC 196 274	Estudio aleatorizado doble ciego, de grupos paralelos y controlado con placebo
T6	PROC 346 354	tratados
#4	AnnotatorNotes T6	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T7	DISO 306 329	enfermedad de Alzheimer
#5	AnnotatorNotes T7	C0002395; Alzheimer's Disease; Disease or Syndrome
T8	CHEM 362 397	inhibidor de la acetilcolinesterasa
T9	CHEM 732 736	IACE
T10	DISO 431 454	Enfermedad de Alzheimer
#6	AnnotatorNotes T10	C0002395; Alzheimer's Disease; Disease or Syndrome
T11	PROC 592 605	diagnosticado
#7	AnnotatorNotes T11	C0011900; Diagnosis; Diagnostic Procedure
T12	DISO 609 611	EA
#8	AnnotatorNotes T12	C0002395; Alzheimer's Disease; Disease or Syndrome
T13	DISO 642 665	enfermedad de Alzheimer
#9	AnnotatorNotes T13	C0002395; Alzheimer's Disease; Disease or Syndrome
T14	PROC 705 716	tratamiento
#10	AnnotatorNotes T14	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T15	PROC 879 904	esterilización quirúrgica
T16	PROC 982 1005	métodos anticonceptivos
#11	AnnotatorNotes T16	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T17	PROC 1038 1047	protocolo
#12	AnnotatorNotes T17	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T18	PROC 1112 1137	esterilización quirúrgica
T19	DISO 1217 1255	signos de enfermedad neurodegenerativa
T20	DISO 1287 1310	trastornos neurológicos
#13	AnnotatorNotes T20	C0027765; nervous system disorder; Disease or Syndrome
T21	DISO 1334 1336	EA
#14	AnnotatorNotes T21	C0002395; Alzheimer's Disease; Disease or Syndrome
T22	DISO 1378 1400	trastorno psiquiátrico
#15	AnnotatorNotes T22	C0004936; Mental disorders; Mental or Behavioral Dysfunction
T23	DISO 1403 1422	trastorno del eje I
#16	AnnotatorNotes T23	C0270287; Axis I diagnosis; Mental or Behavioral Dysfunction
T24	DISO 1542 1544	EA
#17	AnnotatorNotes T24	C0002395; Alzheimer's Disease; Disease or Syndrome
T25	DISO 1569 1575	signos
#18	AnnotatorNotes T25	C0311392; Physical findings; Finding
T26	DISO 1583 1593	enfermedad
#19	AnnotatorNotes T26	C0012634; Disease; Disease or Syndrome
T27	PROC 1645 1683	interrumpir o suspender el tratamiento
#20	AnnotatorNotes T27	C0850893; stop medication; Therapeutic or Preventive Procedure | C4288399; Pharmacotherapy Discontinuation; Therapeutic or Preventive Procedure
T28	CHEM 1688 1692	IACE
T29	CHEM 1757 1766	memantina
#21	AnnotatorNotes T29	C0025242; memantine; Organic Chemical · Pharmacologic Substance
T30	CHEM 278 288	Lu AE58054
#22	AnnotatorNotes T30	C3253508; Lu AE58054; Organic Chemical · Pharmacologic Substance
T31	Date 12 16	2012
T32	LIVB 69 78	pacientes
#23	AnnotatorNotes T32	C0030705; Patients; Patient or Disabled Group
T33	LIVB 292 301	pacientes
#24	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T34	LIVB 486 494	paciente
#25	AnnotatorNotes T34	C0030705; Patients; Patient or Disabled Group
T35	LIVB 504 512	cuidador
#26	AnnotatorNotes T35	C0085537; Caregiver; Professional or Occupational Group | C1305660; Carer (occupation); Professional or Occupational Group
T36	LIVB 538 544	sujeto
#27	AnnotatorNotes T36	C0681850; Study Subject; Group
T37	LIVB 551 571	paciente ambulatorio
#28	AnnotatorNotes T37	C0029921; Outpatients; Patient or Disabled Group
T38	LIVB 578 586	paciente
#29	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T39	Spec_cue 612 620	probable
T40	LIVB 627 635	paciente
#30	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group
T41	LIVB 687 695	paciente
#31	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T43	LIVB 745 750	mujer
#32	AnnotatorNotes T43	C0043210; Woman; Population Group
T44	LIVB 755 763	paciente
#33	AnnotatorNotes T44	C0030705; Patients; Patient or Disabled Group
T45	PHYS 794 806	menstruación
#34	AnnotatorNotes T45	C0025344; Menstruation; Organism Function
T46	Duration 815 824	≥24 meses
T47	LIVB 943 951	paciente
#35	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T49	LIVB 959 964	varon
#36	AnnotatorNotes T49	C0025266; Male population group; Population Group
T51	LIVB 1054 1069	pareja femenina
#37	AnnotatorNotes T51	C0682323; Partner in relationship; Family Group + C0043210; Woman; Population Group
T52	Age 1078 1089	edad fértil
T54	LIVB 1202 1210	paciente
#38	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T55	LIVB 1353 1361	paciente
#39	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group
T57	LIVB 1551 1559	paciente
#40	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T58	Spec_cue 1623 1631	probable
T59	LIVB 1697 1705	paciente
#41	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	LIVB 1732 1740	paciente
#42	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T61	Duration 1785 1796	los 2 meses
T42	Neg_cue 1318 1330	distintos de
T48	Neg_cue 1527 1538	distinto de
T50	PROC 1810 1829	visita de selección
#43	AnnotatorNotes T50	C1710477; Trial Screening; Research Activity + C1512346; Patient Visit; Health Care Activity
T53	PROC 1150 1169	visita de selección
#44	AnnotatorNotes T53	C1710477; Trial Screening; Research Activity + C1512346; Patient Visit; Health Care Activity
T56	PROC 837 856	visita de selección
#45	AnnotatorNotes T56	C1710477; Trial Screening; Research Activity + C1512346; Patient Visit; Health Care Activity
T62	PROC 917 936	visita de selección
#46	AnnotatorNotes T62	C1710477; Trial Screening; Research Activity + C1512346; Patient Visit; Health Care Activity
A1	Assertion T12 Speculated
A6	Assertion T27 Speculated
A2	Status T15 History_of
A3	Status T18 History_of
A4	Assertion T21 Negated
A5	Assertion T24 Negated
#47	AnnotatorNotes T5	C0013072; Double-Blind Method; Research Activity + C0034656; Randomization; Research Activity + C2826345; Parallel Study; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product 
#48	AnnotatorNotes T4	C0001046; Acetylcholinesterase Inhibitors; Pharmacologic Substance 
#49	AnnotatorNotes T8	C0001046; Acetylcholinesterase Inhibitors; Pharmacologic Substance 
#50	AnnotatorNotes T9	C0001046; Acetylcholinesterase Inhibitors; Pharmacologic Substance 
#51	AnnotatorNotes T28	C0001046; Acetylcholinesterase Inhibitors; Pharmacologic Substance 
R1	Negation Arg1:T42 Arg2:T21	
R2	Negation Arg1:T48 Arg2:T24	
R3	Speculation Arg1:T58 Arg2:T27	
R5	Used_for Arg1:T28 Arg2:T27	
R6	Speculation Arg1:T39 Arg2:T12	
T64	CONC 1424 1511	Manual diagnóstico y estadístico de los trastornos mentales, 4ª edición, texto revisado
#53	AnnotatorNotes T64	C0220952; DSM-IV; Intellectual Product (?)
T65	CONC 1513 1522	DSM-IV-TR
#54	AnnotatorNotes T65	C0220952; DSM-IV; Intellectual Product (?)
R7	Experiences Arg1:T55 Arg2:T22	
R8	Experiences Arg1:T55 Arg2:T23	
R9	Experiences Arg1:T55 Arg2:T24	
R10	Experiences Arg1:T57 Arg2:T25	
R11	Experiences Arg1:T57 Arg2:T26	
R12	Causes Arg1:T26 Arg2:T25	
T66	Quantifier_or_Qualifier 1597 1616	importancia clínica
R13	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T66	
R14	Experiences Arg1:T59 Arg2:T27	
T67	PROC 1717 1724	estudio
#55	AnnotatorNotes T67	C0008976; Clinical Trials; Research Activity
R15	Overlap Arg1:T27 Arg2:T67	
R17	Experiences Arg1:T60 Arg2:T29	
R18	Overlap Arg1:T29 Arg2:T61	
R19	Before Arg1:T29 Arg2:T50	
R20	Experiences Arg1:T32 Arg2:T3	
R21	Experiences Arg1:T32 Arg2:T2	
T68	Quantifier_or_Qualifier 330 345	leve o moderada
#56	AnnotatorNotes T68	C1299393; Moderate to severe; Qualitative Concept
R22	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T68	
T69	Quantifier_or_Qualifier 666 681	leve o moderada
#57	AnnotatorNotes T69	C1299393; Moderate to severe; Qualitative Concept
R23	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T69	
T70	Quantifier_or_Qualifier 107 122	leve o moderada
#58	AnnotatorNotes T70	C1299393; Moderate to severe; Qualitative Concept
R24	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T70	
R25	Used_for Arg1:T4 Arg2:T1	
R26	Experiences Arg1:T32 Arg2:T1	
R27	Overlap Arg1:T3 Arg2:T1	
R28	Overlap Arg1:T30 Arg2:T6	
R29	Used_for Arg1:T8 Arg2:T6	
R30	Experiences Arg1:T33 Arg2:T30	
R31	Experiences Arg1:T33 Arg2:T7	
R32	Experiences Arg1:T33 Arg2:T6	
T71	Quantifier_or_Qualifier 513 523	competente
#59	AnnotatorNotes T71	C0086035; Competence; Qualitative Concept
R33	Has_Quantifier_or_Qualifier Arg1:T35 Arg2:T71	
T72	Quantifier_or_Qualifier 526 532	fiable
#60	AnnotatorNotes T72	C3858758; Reliable; Functional Concept
R34	Has_Quantifier_or_Qualifier Arg1:T35 Arg2:T72	
R35	Experiences Arg1:T38 Arg2:T12	
R36	Experiences Arg1:T40 Arg2:T13	
R37	Used_for Arg1:T9 Arg2:T14	
R38	Experiences Arg1:T41 Arg2:T14	
T73	Quantifier_or_Qualifier 717 724	estable
#61	AnnotatorNotes T73	C0205360; Stable status; Qualitative Concept
R39	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T73	
T74	Quantifier_or_Qualifier 787 793	última
#62	AnnotatorNotes T74	C1517741; Last; Qualitative Concept
R40	Has_Quantifier_or_Qualifier Arg1:T45 Arg2:T74	
A8	Status T45 History_of
R41	Experiences Arg1:T43 Arg2:T45	
R42	Experiences Arg1:T44 Arg2:T45	
R43	Overlap Arg1:T45 Arg2:T46	
R44	Before Arg1:T45 Arg2:T56	
T75	Quantifier_or_Qualifier 807 814	natural
A9	Status T75 History_of
#63	AnnotatorNotes T75	C0205296; Natural; Functional Concept
R45	Has_Quantifier_or_Qualifier Arg1:T45 Arg2:T75	
A10	Status T74 History_of
R46	Before Arg1:T15 Arg2:T62	
R47	Experiences Arg1:T43 Arg2:T15	
R48	Experiences Arg1:T44 Arg2:T15	
R49	Before Arg1:T45 Arg2:T62	
R50	Before Arg1:T15 Arg2:T56	
R51	Experiences Arg1:T47 Arg2:T16	
R52	Experiences Arg1:T49 Arg2:T16	
R53	Has_Age Arg1:T51 Arg2:T52	
R54	Experiences Arg1:T47 Arg2:T18	
R55	Experiences Arg1:T49 Arg2:T18	
R56	Before Arg1:T18 Arg2:T53	
T76	Quantifier_or_Qualifier 1006 1015	efectivos
#64	AnnotatorNotes T76	C1704419; Effective; Qualitative Concept
R57	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T76	
R58	Experiences Arg1:T54 Arg2:T19	
T77	Quantifier_or_Qualifier 1259 1278	importancia clínica
R59	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T77	
R60	Experiences Arg1:T54 Arg2:T20	
R61	Experiences Arg1:T54 Arg2:T21	
T78	Quantifier_or_Qualifier 1311 1317	graves
#65	AnnotatorNotes T78	C1547227; Severe - Severity of Illness Code; Intellectual Product
R62	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T78	
R4	Experiences Arg1:T44 Arg2:T56	
R16	Experiences Arg1:T43 Arg2:T56	
R64	Experiences Arg1:T43 Arg2:T62	
R63	Experiences Arg1:T44 Arg2:T62	
R65	Experiences Arg1:T47 Arg2:T53	
R66	Experiences Arg1:T49 Arg2:T53	
R67	Experiences Arg1:T60 Arg2:T50	
#52	AnnotatorNotes T66	C3898777; Important; Qualitative Concept
#66	AnnotatorNotes T77	C3898777; Important; Qualitative Concept
A7	Experiencer T59 Patient
A11	Experiencer T57 Patient
A12	Experiencer T60 Patient
A13	Experiencer T55 Patient
A14	Experiencer T54 Patient
A15	Assertion T49 Hypothetical
A16	Experiencer T49 Patient
A17	Experiencer T47 Patient
A18	Assertion T51 Hypothetical
A19	Experiencer T51 Family_member
A20	Assertion T52 Hypothetical
A21	Assertion T43 Hypothetical
A22	Experiencer T43 Patient
A23	Experiencer T44 Patient
A24	Experiencer T41 Patient
A25	Experiencer T40 Patient
A26	Experiencer T38 Patient
A27	Experiencer T37 Patient
A28	Experiencer T36 Patient
A29	Experiencer T34 Patient
A30	Experiencer T35 Other
A31	Experiencer T32 Patient
A32	Experiencer T33 Patient
